Literature DB >> 9530198

Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors.

M Hamawaki1, T M Coffman, A Lashus, M Koide, M R Zile, M I Oliverio, G DeFreyte, G Cooper, B A Carabello.   

Abstract

Mechanisms controlling cardiac growth are under intense investigation. Among these, the renin-angiotensin system has received great interest. In the current study, we tested the hypothesis that the renin-angiotensin system was not an obligate factor in cardiac hypertrophy. We examined the left ventricular hypertrophic response to a pressure overload in mice devoid of the AT1A receptor, the putative major effector of the growth response of the renin-angiotensin system. Aortic banding produced similar transband gradients in wild-type and AT1A knockout mice. The left ventricular mass-to-body weight ratio increased from 3.44 +/- 0.08 to 5.62 +/- 0.25 in wild-type ascending aortic-banded mice. The response in the knockout mice was not different (from 2.97 +/- 0.13 to 5.24 +/- 0.37). We conclude that the magnitude of cardiac hypertrophy is not affected by the absence of the AT1A receptor and its signaling pathway and that this component of the renin-angiotensin system is not necessary in cardiac hypertrophy.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1998        PMID: 9530198     DOI: 10.1152/ajpheart.1998.274.3.H868

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Knockout of renin-angiotensin system genes: effects on vascular development.

Authors:  D Methot; T L Reudelhuber
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

2.  Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.

Authors:  T Senbonmatsu; S Ichihara; E Price; F A Gaffney; T Inagami
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Doppler estimation of reduced coronary flow reserve in mice with pressure overload cardiac hypertrophy.

Authors:  Craig J Hartley; Anilkumar K Reddy; Sridhar Madala; Lloyd H Michael; Mark L Entman; George E Taffet
Journal:  Ultrasound Med Biol       Date:  2008-02-06       Impact factor: 2.998

Review 4.  What can knockout mice contribute to an understanding of hypertension?

Authors:  L P Audoly; T H Le; T M Coffman
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

5.  Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates.

Authors:  Wesley W Brooks; Chester H Conrad
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

Review 6.  Overview of recent advances in molecular cardiology.

Authors:  Zhongjie Sun
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

7.  Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol.

Authors:  Rafal M Kedzierski; Paul A Grayburn; Yaz Y Kisanuki; Clay S Williams; Robert E Hammer; James A Richardson; Micheal D Schneider; Masashi Yanagisawa
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.

Authors:  Ning Wang; Gerald D Frank; Ronghua Ding; Zhongjia Tan; Amita Rachakonda; Pier Paolo Pandolfi; Takaaki Senbonmatsu; Erwin J Landon; Tadashi Inagami
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade.

Authors:  Kalkidan Bishu; Ozgur Ogut; Sudhir Kushwaha; Selma F Mohammed; Tomohito Ohtani; Xiaolei Xu; Frank V Brozovich; Margaret M Redfield
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

10.  FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca2+ /calmodulin-mediated signalling pathways in vivo and in vitro.

Authors:  Yun-Fei Xiao; Zhi-Xiong Zeng; Xiao-Hui Guan; Ling-Fang Wang; Chan-Juan Wang; Huidong Shi; Weinian Shou; Ke-Yu Deng; Hong-Bo Xin
Journal:  J Cell Mol Med       Date:  2018-04-22       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.